A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

NCT07169851 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Nausea
Vomiting
Drug-Related Side Effects and Adverse Reactions
Neoplasms

Interventions

DRUG: LY3537021
DRUG: Placebo
DRUG: Standard of Care Antiemetic Therapies
DRUG: Background Chemotherapy

Sponsor

Eli Lilly and Company